Lung Cancer Screening Solution

Specialized imaging technology for early detection and diagnosis of lung cancer. Integrates AI-assisted analysis to improve diagnostic accuracy and clinical outcomes.

An integrated diagnostic system that combines radiological and functional screening for pulmonary assessment. The system processes multiple data modalities to enable early detection and accurate patient classification for lung disease management.

Low-dose CT systems optimized for lung cancer screening in high-risk populations. These systems enable early detection with minimized radiation burden.

An artificial intelligence screening solution for lung cancer detection from medical imaging studies. The system generates automated analysis reports to facilitate early detection and diagnosis in pulmonary assessment.

AI-powered software for automated analysis of chest CT images to assist in lung cancer detection and nodule identification. The system utilizes advanced image processing and machine learning algorithms to support radiologists in screening workflows. FDA 510(k) cleared for clinical use in the United States.

Non-invasive screening and diagnostic device for hepatic disease detection and post-diagnostic management in liver disease assessment.

Mobile vehicle-mounted dual-modality cancer screening system designed for field-based diagnostic imaging and cancer detection. Integrates advanced imaging technologies to enable accessible screening in remote or underserved areas. Supports early cancer diagnosis through portable diagnostic capability.

Comprehensive non-invasive screening device for routine health examination and preventive disease detection across multiple organ systems.

Non-invasive respiratory system screening and diagnostic instrument for pulmonary disease detection and monitoring.

Non-invasive breast imaging and screening technology for early detection and diagnostic assessment. Provides support for routine breast health evaluation and risk stratification.

A diagnostic-grade screening system supporting large-scale early screening for populations exceeding one million. It provides an integrated screening and diagnostic workflow applicable to regional and community-level atrial fibrillation and stroke screening and early diagnosis. The system increases detection rate 8-10 times while reducing costs by 80%.

An AI-powered diagnostic system utilizing deep learning algorithms to rapidly identify and localize breast tumors and assess malignancy potential. The system enables efficient screening and characterization of breast lesions from imaging data.